Related Experiment Video

Updated: Jul 25, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients

A Glasmacher1, O A Cornely, K Orlopp

  • 1Medizinische Klinik und Poliklinik I, University of Bonn, Germany. glasmacher@uni-bonn.de

The Journal of Antimicrobial Chemotherapy
|November 26, 2005
PubMed
Abstract

Insights

Caspofungin demonstrated significant efficacy and safety in treating invasive fungal infections in severely ill patients outside of clinical trials. This study highlights its effectiveness in various patient groups, including those with neutropenia and hematologic malignancies.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Caspofungin is an established antifungal agent for empirical therapy in neutropenic patients, refractory invasive Aspergillus infections, and invasive candidiasis.
  • This study presents the largest series of patients treated with caspofungin outside of controlled clinical trials.

Purpose of the Study:

  • To evaluate the efficacy and safety of caspofungin in a real-world setting for patients with invasive fungal infections.
  • To assess treatment outcomes in a diverse group of severely immunocompromised patients.

Main Methods:

  • A retrospective analysis of 118 patients treated with caspofungin across German centers was conducted.
  • Data were collected via detailed questionnaires, focusing on patient demographics, underlying conditions, and treatment outcomes.
  • No influence was exerted on the clinical decision to use caspofungin.

Main Results:

  • Of 106 evaluable patients, 64% achieved complete or partial remission.
  • 70% of patients survived 30 days post-therapy.
  • Similar response rates were observed across different infection severities and pre-treatment statuses; caspofungin was well-tolerated, with no drug-related organ toxicity noted, even with concomitant ciclosporin A use.

Conclusions:

  • Caspofungin exhibits excellent efficacy in treating invasive fungal infections in severely ill patients.
  • The drug demonstrates a very low toxicity profile in this real-world patient cohort.

More Related Videos

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells09:27

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

Published on: April 2, 2021

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...